Tempest Therapeutics, Inc. financial data

Symbol
TPST on Nasdaq
Location
Brisbane, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 203% % -24%
Debt-to-equity 148% % 17%
Return On Equity -311% % -66%
Return On Assets -125% % -51%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4,440,161 shares -90%
Common Stock, Shares, Outstanding 4,440,161 shares -83%
Entity Public Float $53,600,000 USD 235%
Common Stock, Value, Issued $4,000 USD -85%
Weighted Average Number of Shares Outstanding, Basic 4,440,111 shares 124%
Weighted Average Number of Shares Outstanding, Diluted 4,440,111 shares 124%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $13,608,000 USD -0.7%
Operating Income (Loss) $36,418,000 USD -2.2%
Nonoperating Income (Expense) $364,000 USD 253%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $36,054,000 USD -1.5%
Earnings Per Share, Basic 7 USD/shares 85%
Earnings Per Share, Diluted 7 USD/shares 85%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $7,514,000 USD -66%
Other Assets, Current $352,000 USD -8.6%
Assets, Current $8,104,000 USD -66%
Property, Plant and Equipment, Net $681,000 USD -27%
Operating Lease, Right-of-Use Asset $7,825,000 USD -12%
Other Assets, Noncurrent $519,000 USD 16%
Assets $17,129,000 USD -49%
Accounts Payable, Current $922,000 USD -46%
Employee-related Liabilities, Current $103,000 USD -93%
Accrued Liabilities, Current $1,353,000 USD -7.3%
Liabilities, Current $3,525,000 USD -75%
Operating Lease, Liability, Noncurrent $7,258,000 USD -14%
Liabilities $10,783,000 USD -52%
Retained Earnings (Accumulated Deficit) $229,347,000 USD -19%
Stockholders' Equity Attributable to Parent $6,346,000 USD -45%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6,346,000 USD -45%
Liabilities and Equity $17,129,000 USD -49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $8,036,000 USD -12%
Net Cash Provided by (Used in) Financing Activities $721,000 USD -260%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 4,440,161 shares -83%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7,957,000 USD -65%
Interest Paid, Excluding Capitalized Interest, Operating Activities $148,000 USD -55%
Deferred Tax Assets, Valuation Allowance $176,799,000 USD 7.4%
Deferred Tax Assets, Gross $179,336,000 USD 7%
Depreciation $249,000 USD -42%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Property, Plant and Equipment, Gross $2,203,000 USD -4.1%
Operating Lease, Liability, Current $1,147,000 USD 39%
Deferred Tax Assets, Operating Loss Carryforwards $143,896,000 USD 5.1%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $5,239,000 USD 6.4%
Additional Paid in Capital $235,689,000 USD 15%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $2,537,000 USD -15%
Share-based Payment Arrangement, Expense $3,873,000 USD -24%
Interest Expense $1,490,000 USD -2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares